Background: Although primarily a neuronal protein, prion protein (PrP C ) is expressed in the kidney, suggesting a functional role. Results: PrP C facilitates uptake of iron from the glomerular filtrate across kidney proximal-tubule (PT) epithelial cells. Conclusion: PrP C functions as a ferrireductase on the plasma-membrane of PT cells. Significance: A similar function in neuronal cells is likely to cause brain iron-dyshomeostasis in prion disorders.
Brain iron-dyshomeostasis is an important cause of neurotoxicity in prion disorders, a group of neurodegenerative conditions associated with the conversion of prion protein (PrP C ) from its normal conformation to an aggregated, PrP-scrapie (PrP Sc ) isoform. Alteration of iron homeostasis is believed to result from impaired function of PrP C in neuronal iron uptake via its ferrireductase activity. However, unequivocal evidence supporting the ferrireductase activity of PrP C is lacking. Kidney provides a relevant model for this evaluation because PrP C is expressed in the kidney, and ϳ370 g of iron are reabsorbed daily from the glomerular filtrate by kidney proximal tubule cells (PT), requiring ferrireductase activity. Here, we report that PrP C promotes the uptake of transferrin (Tf) and non-Tf-bound iron (NTBI) by the kidney in vivo and mainly NTBI by PT cells in vitro. Thus, uptake of 59 Fe administered by gastric gavage, intravenously, or intraperitoneally was significantly lower in PrPknock-out (PrP ؊/؊ ) mouse kidney relative to PrP ؉/؉ controls. Selective in vivo radiolabeling of plasma NTBI with 59 Fe revealed similar results. Expression of exogenous PrP C in immortalized PT cells showed localization on the plasma membrane and intracellular vesicles and increased transepithelial transport of 59 Fe-NTBI and to a smaller extent 59 Fe-Tf from the apical to the basolateral domain. Notably, the ferrireductasedeficient mutant of PrP (PrP ⌬51-89 ) lacked this activity. Furthermore, excess NTBI and hemin caused aggregation of PrP C to a detergent-insoluble form, limiting iron uptake. Together, these observations suggest that PrP C promotes retrieval of iron from the glomerular filtrate via its ferrireductase activity and modulates kidney iron metabolism.
Prion protein (PrP C ) 3 is a ubiquitously expressed, evolutionarily conserved plasma membrane glycoprotein that is most abundant on neuronal cells. A change in its conformation from mainly ␣-helical to a ␤-sheet-rich PrP-scrapie (PrP Sc ) isoform is the key event underlying the pathogenesis of prion disorders, a group of invariably fatal neurodegenerative conditions of humans and animals (1, 2) . The physiological function of PrP C or the mechanism of neurotoxicity by PrP Sc , however, remains unclear. Cumulative evidence indicates brain iron dyshomeostasis as a prominent feature of human and animal prion disorders, implicating redox-active iron in disease-associated neurotoxicity (3, 4) . The underlying cause of iron dyshomeostasis is not clear, although recent reports suggest loss or altered function of PrP C in cellular iron uptake via its ferrireductase (FR) activity as a possible cause (5) . Although demonstrated in neuroblastoma cells expressing exogenous PrP C in vitro (5) , unequivocal evidence supporting PrP C -associated FR activity in vivo is lacking mainly because of the complex nature of regulation of the iron redox state as well as transport into different compartments in the brain.
Kidney provides a convenient and relevant model to explore this question for two main reasons. First, ϳ370 g of iron are filtered through the glomeruli daily, 99% of which is reabsorbed with the help of iron uptake and transport proteins expressed on the apical (AP) plasma membrane of epithelial cells lining the proximal (PT) and distal tubules. In vivo in the steady state, absorbed iron is exported to the interstitium and capillary blood across the basolateral (BL) membrane of PT cells (6 -8) . The transport of iron between different body, cell, and subcellular compartments is complicated because the known membrane transporters for iron (8) accept only the more soluble ferrous form (Fe 2ϩ ), whereas the majority of iron in the extracellular fluid and serum is in the more stable ferric form (Fe 3ϩ ) bound to either transferrin (Tf) or small molecules (non-Tf bound iron or NTBI). Hence, there is a need for iron redox enzymes close to the site of membrane transport (see Fig. 8 for models). Therefore, we hypothesized that iron uptake by PT cells requires FR activity on the AP plasma membrane given that the majority of iron in the glomerular filtrate exists as Fe 3ϩ bound to Tf or as NTBI. Tf-iron is endocytosed by the cubilin-megalin receptor complex or transferrin receptor expressed on the AP plasma membrane of PT cells, and Fe 3ϩ released from Tf in acidic endosomes is reduced by membrane-bound FR proteins before transport to the cytosol through divalent metal transporter 1 (DMT1) or the ZIP family of proteins (8 -11) . NTBI, on the other hand, requires reduction from Fe 3ϩ to the Fe 2ϩ form on the plasma membrane before uptake by DMT1 or ZIP proteins expressed on the AP plasma membrane of PT cells. Major known FR proteins in these cells include duodenal cytochrome b on the AP plasma membrane and Steap3 in the membrane of acidic endosomes (12, 13) . Iron transported to the cytosol is utilized for metabolic purposes, oxidized by ferritin, and stored in its shell or exported from the BL membrane by the coupled action of ferroportin and hephaestin, a ferroxidase that oxidizes exported Fe 2ϩ to Fe 3ϩ for conjugation with circulating apoTf to form diferric-Tf (Tf-iron) (4, 14) . Second, expression of PrP C has been described in the kidney (15, 16) , and significant amounts of full-length, truncated, and various glycosylated forms of PrP C are present in the urine of healthy individuals (17) (18) (19) . It is remarkable that the majority of PrP C in the urine is similar to the anchorless, N-terminally processed form observed in human and animal brains and neuronal cell models, suggesting similar processing of PrP C by kidney epithelial and cortical neuronal cells (20 -22) . More importantly, the presence of PrP C in the urine of healthy individuals suggests that it is expressed on PT cells where it may provide FR activity necessary for the uptake of Tf-iron and NTBI (4, 5, 17) .
To explore this possibility, we evaluated the role of PrP C in iron uptake by the kidney in transgenic mouse models lacking PrP (PrP Ϫ/Ϫ ) (23) and immortalized mouse PT cells that differ-entiate in culture to form functional monolayers with tight junctions (24) . These cells express relatively low levels of endogenous PrP C and thus provide a useful model for the evaluation of exogenously expressed human PrP C and its FR-deficient mutant PrP ⌬51-89 in iron uptake and transport (5) . 4 Here, we report that PrP C promotes the uptake and transport of NTBI and Tf-iron from the glomerular filtrate in vivo and mainly NTBI across PT cells in vitro through its FR activity. However, excess NTBI and hemin aggregate PrP C to a detergent-insoluble form, preventing further iron uptake. Antibodies and Reagents-Culture media, culture supplements, and Hoechst stain were obtained from Invitrogen. Filter supports were obtained from Corning Life Sciences (Teksbury, MA). Primary antibody to PrP (3F4) was acquired from Signet Laboratories (Dedham, MA). Anti-ferritin antibody and hemin were from Sigma, and antibodies to Tf and actin were from Millipore (Bedford, MA). Horseradish peroxidase-conjugated secondary antibodies and an ECL detection kit were obtained from GE Healthcare. Rhodamine-conjugated Tf and Lyso-Tracker Red were from Invitrogen. 59 FeCl 3 was obtained from PerkinElmer Life Sciences. All other chemicals were obtained from Sigma.
EXPERIMENTAL PROCEDURES
Iron Uptake in Vivo-Age-and sex-matched PrP ϩ/ϩ and PrP Ϫ/Ϫ mice were either gavage-fed or injected intravenously or intraperitoneally with 59 Fe-citrate diluted in normal saline as described in previous reports (5, 25) . For the specific radiolabeling of NTBI, serum Tf was saturated with excess unlabeled iron by injecting ferric-ammonium citrate (FAC) (70 g/22 g of mouse) intraperitoneally followed by 59 Fe-citrate after an interval of 30 min (26). Animals were euthanized at the indicated times, and blood was collected by cardiac puncture. Harvested kidneys were rinsed in cold PBS, and associated 59 Fe was measured in a ␥-counter (Beckman Gamma 5500).
Expression Constructs-Plasmid constructs expressing fulllength human PrP C and PrP ⌬51-89 with and without green fluorescent protein (GFP) inserted between amino acids 38 and 39 of PrP have been described in previous reports (27) (28) (29) . Relevant sequences were subcloned into the eukaryotic PiggyBac vector p748 and confirmed by sequencing before transfection in PT cells. Transfected cells were selected in the presence of blasticidin S, and stable cell lines were used for all experiments.
Cell Lines and Culture Conditions-Monolayers of immortalized PT cells were maintained and differentiated as described in a previous report (24) . Cells were cultured on 0.4-m poresize hanging filter inserts (Corning Costar, Tewksbury, MA) in DMEM (without glucose) and Ham's F-12 medium in a 1:1 ratio supplemented with 5% heat-inactivated fetal bovine serum (FBS), penicillin-streptomycin-Fungizone mixture (1ϫ), HEPES (15 mM), sodium bicarbonate (NaHCO 3 ) (0.06%), transferrin (5 g/ml), ascorbic acid (50 M), selenium (20 nM), 5-triiodothyronine (1 nM), insulin (5 g/ml), epithelial growth factor (EGF) (10 ng/ml), interferon-␥ (IFN-␥; 10 ng/ml), and dexamethasone (4 g/ml). Cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . Monolayers with transepithelial electrical resistance of 200 -250 ohms/cm 2 were differentiated at 39°C in medium lacking insulin, IFN-␥, and EGF. Apical medium also lacked FBS. Differentiated monolayers with a transepithelial electrical resistance value Ͼ500 ohmscm 2 were used for iron transport studies.
SDS-PAGE, Western Blotting, and Native Gel Electrophoresis-Cell lysates were fractionated by SDS-PAGE, and Western blotting and probing for different proteins was performed as described in previous reports (27) (28) (29) . 59 Fe-labeled samples were fractionated by native PAGE and visualized by autoradiography as described (5, 25, 29) . Densitometry of fluorograms and autoradiographs was performed using UN-SCAN-IT gel (Version 6.1) software (Silk Scientific) and graphically represented with GraphPad Prism (Version 5.0) software (GraphPad Software Inc.).
Immunostaining-Stable cell lines expressing GFP-tagged PrP C or PrP ⌬51-89 were polarized on filter inserts, and images of live cells were captured by confocal microscopy (Olympus FV1000). Individual image stacks were processed with Fiji (30) . Alternately, polarized cells expressing untagged PrP C were fixed, permeabilized, and immunostained for PrP and ZO-1 as described (31) . For evaluating colocalization of PrP C-GFP with Tf, cells were exposed to 50 g/ml rhodamine-conjugated Tf for 5 min at 37°C, washed with complete medium 3 times, chased for 15 min, and imaged as above. To evaluate colocalization with LysoTracker Red, PrP C-GFP -cells were exposed to 75 M LysoTracker at 37°C for 30 min and washed 3 times with complete medium, and images of live cells were captured.
Iron Transport across Monolayers of PT Cells-Transport assays were carried out with apical and basolateral differentiation media in the respective chambers to ensure cell viability. ApoTf (39 M) was added to the opposite chamber to serve as a sink for transported 59 Fe 3ϩ (32) . 59 Fe-citrate and 59 Fe-Tf were prepared as described (34), equal counts mixed with [ 3 H]inulin were added to the AP or BL chamber, and distribution of 59 Fe in the AP, BL, and intracellular compartments was measured as 59 Fe counts in a ␥-counter and by fractionating samples on a native gel. 59 Fe-labeled bands were visualized by autoradiography and quantified by densitometry. Integrity of the monolayer was confirmed by quantifying simultaneous transport of [ 3 H]inulin at different time points. To evaluate incorporation of 59 Fe in cellular ferritin, monolayers were washed twice with ice-cold PBS, lysed in native lysis buffer as described (29) , and resolved on native gel as above.
RESULTS
Absence of PrP C Reduces Iron Uptake by the Kidney-Ageand sex-matched PrP ϩ/ϩ and PrP Ϫ/Ϫ mice were exposed to radiolabeled iron ( 59 Fe-citrate) by gavage feeding and intravenous (IV) or intra-peritoneal (IP) route, and uptake of 59 Fe by the kidney was quantified in a ␥-counter ( Fig. 1, A-C) . 59 Fecitrate introduced by gavage feeding is expected to radiolabel mainly plasma Tf, whereas injection by the intravenous and intraperitoneal routes is likely to radiolabel both Tf and NTBI but preferentially Tf because of its high affinity for iron. Specific radiolabeling of NTBI was achieved by saturating plasma Tf with an intraperitoneal injection of excess unlabeled FAC fol- lowed by 59 Fe-citrate after an interval of 30 min (Fig. 1, D-F ) (26) .
Uptake of 59 Fe by the PrP Ϫ/Ϫ kidney was significantly lower relative to PrP ϩ/ϩ controls 24 h after gavage feeding and 4 h after intravenous administration of 59 Fe-citrate (Fig. 1, A and  B) . A similar pattern was noted 6 and 24 h after intraperitoneal injection of 59 Fe-citrate, although the counts decreased significantly and were equivalent in both mouse lines after 72 h due to possible redistribution of 59 Fe in hematopoietic cells (Fig. 1C) . Preferential radiolabeling of circulating NTBI revealed the presence of 59 Fe-NTBI in the kidneys of both mouse lines and significantly less incorporation by PrP Ϫ/Ϫ kidney relative to PrP ϩ/ϩ controls (Fig. 1D ). Evaluation of kidney tissue by native gel electrophoresis followed by autoradiography revealed reduced levels of 59 Fe-ferritin in PrP Ϫ/Ϫ samples relative to PrP ϩ/ϩ controls, explaining the above observations (Fig. 1, E  and F) . It is notable that the signal for 59 Fe-Tf (residual iron-free Tf radiolabeled by 59 Fe-citrate) is equivalent in PrP Ϫ/Ϫ and PrP ϩ/ϩ samples (Fig. 1E ), suggesting that the majority of 59 Fe in kidney tissue ferritin is from the uptake of 59 Fe-NTBI ( Fig. 1 , E, lane 2, and F). These observations suggest that PrP C plays a significant role in the uptake of Tf-iron and NTBI and is likely to influence a pathway common to the uptake and utilization of both forms of iron.
PrP C Is Localized to the Plasma Membrane and Intracellular Vesicles of Proximal Tubule Cells-To evaluate the mechanism by which PrP C influences the uptake and transport of iron across PT cells, stable clones of mouse PT cells expressing GFPtagged PrP C (PrP C-GFP ) and its FR-deficient mutant PrP ⌬51-89 (PrP ⌬51-89-GFP ) ( Fig. 2A) were cultured on filter supports to obtain polarized monolayers with tight junctions, and confocal images of live cells were captured at different depths (Fig. 2B) . XY-stacks revealed expression of PrP C-GFP and PrP ⌬51-89-GFP at the plasma membrane and intracellular vesicles. Immunostaining of endogenous mouse PrP C in non-transfected cells revealed a similar localization of PrP C , making it unlikely that intracellular localization is due to overexpression of transfected PrP (data not shown). The presence in vesicular structures was surprising as PrP C and PrP ⌬51-89 are expressed mainly on the plasma membrane of neuronal cells with some reactivity in the Golgi area (28, 33) . To confirm these observations, polarized PT cells expressing non-GFP-tagged PrP C and PrP ⌬51-89 were permeabilized with Triton-X and co-immunostained with antibody specific to human PrP C (green) and the tight junction protein ZO-1 (red) (Fig. 2C ). Z-stacks of captured images revealed significant PrP C reactivity on the plasma membrane and in intracellular vesicles as for GFP-tagged forms (Fig. 2C, panel 1) . ZO-1 staining was prominent at the plasma membrane and co-localized with PrP C at tight junctions (Fig. 2C, panels 2 and  3) . Z-sections revealed mainly AP and intracellular localization of PrP C , although some reactivity was detected near the BL membrane ( Fig. 2D, panel 1) . colocalization of PrP C with ZO-1 was evident at the tight junctions ( Fig. 2D, panels 2 and 3) . A similar expression pattern was noted for PrP ⌬51-89 (data not shown).
To identify the intracellular vesicles where PrP C is localized, polarized PT cells expressing PrP C-GFP were incubated with rhodamine-conjugated Tf (Fig. 3A) or LysoTracker Red (Fig.  3B) , and cells were fixed after defined time points of incubation. Confocal imaging revealed colocalization of PrP C-GFP with Tf in ϳ22% and with LysoTracker in 26% of intracellular vesicles in the majority of cells. There was no obvious difference in the distribution of PrP ⌬51-89-GFP relative to PrP C-GFP under similar conditions (data not shown).
PrP C Stimulates the Uptake and Transport of NTBI across Proximal Tubule Cells-To evaluate whether exogenous expression of PrP C and, in particular, its FR activity influences the uptake and transport of NTBI and Tf-iron across PT cells, polarized monolayers of non-transfected and PrP C -and PrP ⌬51-89 -transfected cells were cultured in uptake medium, and physiological concentrations of apoTf were added to the BL medium to mimic in vivo conditions and provide a sink for transported 59 Fe (Figs. 4 and 5 ). Equal counts of 59 Fe-citrate were added to the AP chamber of duplicate filters of each cell line, and transport of 59 Fe to the BL chamber was monitored by counting equal aliquots of medium from the AP and BL chamber after 1, 2, 4, and 7 h in a ␥-counter (32). PrP C -expressing cells transported 2-3 times more 59 Fe to the BL chamber rela-tive to PrP ⌬51-89 and non-transfected controls after 4 and 7 h (Fig. 4A) .
To ascertain the distribution of apically added 59 Fe-citrate, equal aliquots of medium collected after 1, 4, and 7 h and cell lysates prepared from 7-h samples were fractionated by native-PAGE followed by autoradiography. Evaluation of AP, BL, and intracellular pools of 59 Fe revealed a more complex distribution than the directional transport across the monolayer indicated in Fig. 4A . Examination of autoradiograms revealed four distinct pools of 59 Fe (Fig. 4B ): 1) transcytosed 59 Fe in association with apoTf in the BL chamber (arrowhead), 2) 59 Fe at the gelfront of AP samples, 3) 59 Fe-Tf in AP samples resulting from the association of 59 Fe-citrate with apoTf transported from the BL chamber ( Fig. 5A and 4 ) 59 Fe in cellular ferritin in 7-h lysate samples.
The signal for 59 Fe-Tf increased in all cell lines with increased incubation time, indicating continuous efflux of 59 Fe from cells into the BL medium (Fig. 4B, arrowhead) . Quantification of 59 Fe-Tf in aliquots from the BL chamber as a percent of the total ( 59 Fe at the gel-front ϩ 59 Fe-Tf in AP samples ϩ 59 Fe-ferritin) revealed 2-3-fold higher levels in cells expressing PrP C relative to vector and PrP ⌬51-89 -expressing cells after 1 and 4 h, supporting the data in panel A (Fig. 4, B, white stars,  and D) . However, redistribution of 59 Fe to the AP and intracellular compartments after 7 h resulted in decreased 59 Fe-Tf in the BL chamber of all cell lines (Fig. 4, B and D) . Surprisingly, 59 Fe-Tf in BL samples migrated slower than AP 59 Fe-Tf and displayed a distinct doublet, suggesting post-translational processing in the intracellular compartment(s) (Fig. 4B, arrowhead) . When 59 Fe-citrate was added to the BL chamber of all three cell lines, minimal transport was noted after 1, 4, and 7 h (Fig. 4, C and E) . A small amount of apoTf added to the AP chamber gets transported to the BL chamber (Fig. 5B ). A similar evaluation of 59 Fe-Tf added to the AP chamber revealed a small increase in BL transport by cells expressing PrP C (Fig. 6, A, lanes 6 and 7, and C) . However, basolaterally added 59 Fe-Tf did not redistribute to the AP or intracellular compartments in any cell line within the 7 h examined (Fig. 6, B,  lanes 1-28, and D) . Together, the above data demonstrate that PrP C facilitates AP to BL transport of NTBI and to a small extent Tf-iron across PT cells, and the FR-activity of PrP C is essential for this function.
Excess NTBI and Hemin Cause Aggregation of PrP C -PrP C expressed on neuronal cells is known to aggregate when exposed to excess NTBI or hemin (35, 36) . A similar reaction is likely to occur under pathological conditions when NTBI and/or hemin filtered through the glomeruli come in contact with PrP C on the plasma membrane of PT cells (8) . To evaluate this possibility, PT cells expressing PrP C or PrP ⌬51-89 were exposed to hemin or FAC overnight, and lysates were subjected to Western blotting and probed for PrP and ␤-actin (Fig. 7 , A-C). PrP ⌬51-89 served as a negative control because it lacks FR activity (5) and does not bind hemin (36) . Exposure to hemin induced aggregation of PrP C , whereas PrP ⌬51-89 was unaffected ( Fig. 7, A, lanes 4 and 6, and B, lanes 2 and 5, *; longer exposures in the upper panels highlight hemin-induced aggregation of PrP C ). Likewise, exposure to FAC induced aggregation of PrP C but had minimal effect on PrP ⌬51-89 (Fig. 7B, lanes  3 and 6) .
To evaluate whether exposure to hemin or FAC alters the detergent solubility of PrP C , hemin-and FAC-exposed cells were lysed in a buffer containing non-ionic detergents, and clarified extracts were centrifuged at high speed to separate the detergent-soluble (S) and insoluble (P) fractions (33, 37) . All fractions were resolved by SDS-PAGE, and transferred proteins were probed for PrP and ␤-actin (Fig. 7C ). PrP C from untreated samples partitioned mainly in the detergent-soluble fraction as expected (Fig. 7C, lanes 3 versus 4) , whereas exposure to hemin or FAC resulted in the partitioning of ϳ50% of PrP C in the -28) . 59 Fe-ferritin ϩ 59 Fe-Tf were resolved in parallel (lane 1). C, transport of 59 Fe-Tf from the AP to the BL chamber as a percent of the total ( 59 Fe at the dye-front ϩ AP 59 Fe-Tf ϩ 59 Fe-ferritin) is 4.6% in PrP C -expressing cells relative to 2% and undetectable in Vec and PrP ⌬51-89 -expressing cells respectively. D, similar quantification of BL to AP transport of 59 Fe-Tf shows minimal signal in the AP chamber after 1, 4, and 7 h. L, lysate; P, pellet. detergent-insoluble pellet fraction (Fig. 7C, lanes 1 versus 2; lanes 5 versus 6). ␤-Actin partitioned mainly in the soluble fraction ( Fig. 5 C, lanes 1, 3, and 5) . Thus, excess FAC (NTBI) and hemin induce aggregation of PrP C to a non-functional, detergent-insoluble form.
DISCUSSION
This report demonstrates that PrP C promotes re-absorption of iron from the glomerular filtrate via its FR activity. Uptake of 59 Fe-Tf and 59 Fe-NTBI was significantly reduced in PrP Ϫ/Ϫ mouse kidney under a variety of experimental conditions, indicating that duodenal cytochrome b and other well characterized FR proteins are unable to compensate fully for the absence of PrP C . Exogenously expressed PrP C in PT cells increased transepithelial transport of 59 Fe-NTBI and, to a lesser extent, 59 Fe-Tf from the AP to the BL domain. Minimal transport of 59 Fe-NTBI or 59 Fe-Tf was noted in the opposite direction in the absence or presence of PrP C , suggesting mainly unidirectional transport of iron from the glomerular filtrate to the kidney interstitium and increased kinetics of transport in the presence of PrP C . These observations are consistent with reports indicating the absence of major iron uptake proteins on the BL mem-brane of proximal and distal tubule cells, suggesting minimal uptake of iron from the blood stream (6, 8) . Notably, PrP ⌬51-89 had minimal effect on the uptake or transport of iron, highlighting the functional significance of FR activity of PrP C at this site. Aggregation of PrP C by excess NTBI and hemin confirmed similar observations in neuroblastoma cells (35, 36) and suggested a protective role of PrP C in the kidney against iron and hemininduced nephrotoxicity.
It is notable that PrP Ϫ/Ϫ kidney showed reduced incorporation of 59 Fe when introduced by gastric gavage, intravenously, intraperitoneally, and after saturation of plasma Tf with unlabeled iron. Because these routes of administration radiolabel mainly Tf-iron, NTBI, or both, these observations leave little doubt that PrP C participates in a pathway that is common to these forms of iron. The most likely possibility is FR activity of PrP C (5) because reduction to Fe 2ϩ is necessary for the uptake and transport of both Tf-iron(Fe 3ϩ ) and NTBI(Fe 3ϩ ) across the plasma membrane or organelle membrane into the cytosol through divalent metal transporters (38, 39) .
Our data on PT cells support the above assumption. Expression of PrP C , but not its FR-deficient mutant PrP ⌬51-89 , promoted transepithelial transport of 59 Fe-citrate from the AP to , asterisk) . B, a comparative evaluation of PrP C and PrP ⌬51-89 cells exposed to hemin or FAC shows aggregation of PrP C by both treatments (lanes 1-3) . Aggregation by hemin is significantly more than FAC (lanes 2 and 3,  asterisk) . Neither treatment has any effect on PrP ⌬51-89 -expressing cells (lanes 4 -6) . C, detergent-soluble and insoluble lysate fractions from PrP C -expressing cells exposed to FAC or hemin shows partitioning of almost all PrP C from control samples in the detergent-soluble supernatant (S) fraction as expected (lanes  3 and 4) . In contrast, ϳ50% of PrP C from FAC and hemin-treated lysates partitions in the detergent-insoluble pellet (P) fraction, indicating aggregation (lanes 1 and 2 and lanes 5 and 6) . ␤-Actin partitions in the soluble fraction.
the BL domain. The preferential effect of PrP C on the transport of NTBI relative to Tf-iron suggests that PrP C serves as a FR on the AP plasma membrane of PT cells to facilitate the uptake and transport of NTBI through DMT1 and ZIP proteins. A small but significant positive effect of PrP C on the AP to BL transport of Tf-iron combined with colocalization of PrP C with Tf in recycling and late endosomes suggests a similar function in these compartments where it resides during recycling from the plasma membrane (20, 40, 41) . The cellular distribution of PrP C on the AP plasma membrane and intracellular vesicles with minimal expression on the BL membrane is consistent with the above conclusions.
The mechanism by which PrP C mediates transepithelial transport of NTBI across PT cells is not clear from our data. It was surprising to note that a significant amount of PrP C in PT cells was localized to recycling endosomes or late endosomes and lysosomes, a distribution markedly different from the mainly plasma membrane expression on neuronal cells (33, 42, 43) . This can be explained by the large apical endocytosis activity of proximal tubule cells responsible in vivo for the uptake of a large daily load of small filtered proteins (6, 8) . The appearance of a post-translationally modified form of 59 Fe-Tf in the BL chamber of cells exposed to 59 Fe-citrate from the AP domain suggests that endocytic vesicles containing PrP C and 59 Fe intermix with BL vesicles containing apoTf-and Golgiderived vesicles, resulting in the generation of modified 59 Fe-Tf that migrates as a doublet on native gels. Intermixing of AP and BL vesicles and sorting and targeting of endocytosed molecules to domain-specific membrane microdomains has been described in other polarized cells, including the kidney-derived Madin-Darby canine kidney cell line, and is a distinct possibility in the PT cells described here (44 -46) . Further exploration is necessary to understand these observations fully. Fig. 8 represents a model outlining the known pathways of iron uptake and transport by PT cells and the novel role of PrP C identified in this study.
Aggregation of PrP C by excess NTBI and hemin was not surprising as a similar phenomenon has been described in neuroblastoma cells (35, 36) . However, the universality of this phenomenon regardless of the microenvironment suggests an inherent susceptibility of PrP C to metal-induced oxidative stress. Such a response of PrP C in PT cells has physiological implications as NTBI and hemin are nephrotoxic and are likely to leak into the glomerular filtrate under a variety of pathological conditions (47) (48) (49) . Aggregation of PrP C in response to these agents is, therefore, likely to serve a protective role by reducing further iron uptake by the kidney.
However, aggregation of PrP C on neuronal cells in response to any stimulus, including conversion to PrP Sc , is likely to induce neuronal iron deficiency. The unequivocal demonstration of FR activity of PrP C in this report suggests that brain iron imbalance in prion disorders is probably triggered by loss of function of PrP C in iron uptake, stimulating alternative mechanisms of iron acquisition. Such a response in the presence of continuous conversion of PrP C to the PrP Sc is likely to induce brain iron dyshomeostasis, a prominent contributing cause of neurotoxicity in prion disorders (3, 50) . Known pathways indicate internalization of Fe 3ϩ associated with Tf or NGAL by transferrin receptor1 (TfR1), TfR2, cubilin, megalin, or NGAL-receptor and release of Fe 3ϩ in acidic endosomes. After reduction by duodenal cytochrome b, Fe 2ϩ is transported to the cytosol through DMT1 or the ZIP proteins (8) . The receptor-protein complex is transported back to the plasma membrane. Fe 2ϩ in the labile iron pool is utilized for metabolic processes, oxidized, and stored in ferritin or exported from the BL membrane through the coupled action of ferroportin and the ferroxidase hephaestin for conjugation with apoTf in circulating blood. Exchange of Fe 2ϩ between late endosomes/ lysosomes and the cytosol through metal transporters has also been described (38, 51) . Proposed new pathways based on this report suggest reduction of Fe 3ϩ -NTBI by PrP C at the plasma membrane and recycling endosomes for transport to the cytosol through DMT1 and the ZIP proteins. In addition, AP vesicles carrying Fe 3ϩ intermix with Golgi-derived vesicles and basolateral recycling endosomes, allowing association of Fe 3ϩ from the AP domain to apoTf from the BL domain and glycosylation of diferric-Tf before domain-specific sorting and recycling of Tf-iron. A small amount of apoTf is transported to the opposing chamber through vesicular transport or other mechanisms. TJ, tight junction; Glom. Fil., glomerular filtrate; E, endosomes; L, lysosome; N, nucleus; M, mitochondrion; G, Golgi; Fpn, ferroportin; Hp, hephaestin; Dyctb, duodenal cytochrome B.
In conclusion, this report provides evidence supporting the ferrireductase activity of PrP C in the kidney in vivo and in vitro, partly explaining the cause of iron dyshomeostasis in prion disease-affected brains. Further exploration is necessary to understand the significance of PrP C in neuronal iron metabolism and the consequence(s) of loss or alteration of this function in prion disease pathogenesis.
